Target intelligence / Profile preview

Glutamate receptor ionotropic, NMDA 2C (GluN2C)

Target
GluN2C
Molecular classification
Ion channel, Ionotropic glutamate receptor, Ligand-gated ion channel, Receptor
01

Overview

The Glutamate receptor ionotropic, NMDA 2C is a specific subunit of the N-methyl-D-aspartate (NMDA) receptor complex, which functions as a ligand-gated cation channel essential for excitatory signaling in the central nervous system [1, 2]. Predominantly expressed in the cerebellum, olfactory bulb, and thalamus, this subunit forms heteromeric complexes with GluN1 that exhibit unique biophysical characteristics, such as a weaker voltage-dependent magnesium block and lower single-channel conductance compared to other NMDA subtypes [2]. These properties allow the receptor to modulate neuronal excitability and contribute significantly to tonic excitatory currents and synaptic plasticity, particularly in motor and sensory circuits [2, 3]. Genetic variations or functional imbalances in this molecule are linked to several neuropsychiatric and neurological conditions, including schizophrenia, epilepsy, and movement disorders [1, 4]. While established therapeutics like memantine target NMDA receptors broadly, this specific subunit is a focus for the development of selective allosteric modulators intended to treat cognitive and motor deficits with high precision [4, 5]. Research tools like CIQ and DQP-1105 have been instrumental in defining the therapeutic potential of modulating this receptor in isolation from its more widely distributed counterparts [3, 5].

Other names
NR2CGRIN2CNMDAR2CN-methyl D-aspartate receptor subtype 2CGlutamate [NMDA] receptor subunit epsilon-3
02

Mechanism of action

Drugs targeting the GluN2C-containing NMDA receptors typically function as either uncompetitive channel blockers, which obstruct the ion pore during activation to prevent cation influx, or as allosteric modulators that bind to specific domains to either potentiate (positive allosteric modulators) or reduce (negative allosteric modulators) the channel's response to the endogenous agonists glutamate and glycine [2, 5]. Some compounds specifically target the glycine-binding site to modulate the receptor's sensitivity and gating kinetics [3, 4].

03

Biological functions

Excitatory synaptic transmissionSynaptic plasticityCation transportCerebellar signalingNeurotransmissionCalcium signaling
04

Disease associations

SchizophreniaEpilepsyNeurodevelopmental disorderParkinson's diseaseAtaxiaAlzheimer's disease
05

Safety considerations

AtaxiaMotor discoordinationCognitive impairmentDissociative symptomsHallucinationsSedation
06

Interacting drugs

Memantine

6 more in the full profile.

07

Biomarkers

GRIN2C genetic variantsCerebellar volume (MRI)Glutamate levels in cerebrospinal fluidNMDA receptor autoantibodies

Beyond the preview

Go deeper on Glutamate receptor ionotropic, NMDA 2C (GluN2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic, NMDA 2C (GluN2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call